Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 312.50 | 257.33 | 414.00 | 434.50 | 0.9528 | 0.8761 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 312.50 | 257.33 | 375.00 | 434.50 | 0.8631 | 0.6459 |
SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 312.50 | 257.33 | 271.00 | 434.50 | 0.6237 | 0.0709 |
SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 483.00 | 434.50 | 1.1116 | 1.3006 | |
SK-BR-3 | Palbociclib | 1 | uM | 3 | 312.50 | 257.33 | 434.00 | 434.50 | 0.9989 | 0.9970 |
SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 312.50 | 257.33 | 193.00 | 434.50 | 0.4442 | -0.3166 |
SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 541.00 | 434.50 | 1.2451 | 1.6731 | |
SK-BR-3 | Omipalisib | 1 | uM | 3 | 312.50 | 257.33 | 234.00 | 434.50 | 0.5386 | -0.1182 |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 312.50 | 257.33 | 468.00 | 434.50 | 1.0771 | 1.2065 |
SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 312.50 | 257.33 | 439.00 | 434.50 | 1.0104 | 1.0275 |
SK-BR-3 | Taxol | 0.001 | uM | 3 | 312.50 | 257.33 | 397.00 | 434.50 | 0.9137 | 0.7748 |
SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 312.50 | 257.33 | 489.00 | 434.50 | 1.1254 | 1.3385 |
SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 312.50 | 257.33 | 318.00 | 434.50 | 0.7319 | 0.3233 |
SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 561.00 | 434.50 | 1.2911 | 1.8046 |
SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 454.00 | 434.50 | 1.0449 | 1.1196 | |
SK-BR-3 | Palbociclib | 10 | uM | 3 | 312.50 | 257.33 | 318.00 | 434.50 | 0.7319 | 0.3233 |
SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 312.50 | 257.33 | 295.00 | 434.50 | 0.6789 | 0.1981 |
SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 353.00 | 434.50 | 0.8124 | 0.5193 | |
SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 316.00 | 434.50 | 0.7273 | 0.3123 | |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 941.00 | 1123.25 | 0.8378 | 0.6790 | |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1089.00 | 1123.25 | 0.9695 | 0.9397 | |
SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 625.00 | 556.96 | 895.00 | 1123.25 | 0.7968 | 0.5979 |
SK-BR-3 | Taxol | 0.31623 | uM | 3 | 625.00 | 556.96 | 421.00 | 1123.25 | 0.3748 | -0.2416 |
SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 625.00 | 556.96 | 1013.00 | 1123.25 | 0.9019 | 0.8059 |
SK-BR-3 | Methotrexate | 10 | uM | 3 | 625.00 | 556.96 | 1262.00 | 1123.25 | 1.1235 | 1.2439 |